Both in Biotechnology
BioStem Technologies vs Estrella Immunopharma
Over the past year BSEM returned −73.3% and ESLA returned −32.8%; their daily moves had a correlation of 0.04.
BSEM −73.3% ESLA −32.8%Growth of $1, one year, split-adjusted
| Metric | BSEM | ESLA |
|---|---|---|
| Price | $1.15 | $0.4435 |
| Market cap | $21.5M | $19.3M |
| Today | 0.00% | +6.10% |
| 1 month | −53.4% | +3.4% |
| 6 months | — | −65.9% |
| Year to date | — | −71.6% |
| 1 year | — | −85.5% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | — | $146.7K |
| Dividend yield | — | — |
| Volatility (60d) | — | 201.6% |
| Short % of float | 2.3% | 4.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).